267 related articles for article (PubMed ID: 11045731)
1. Comparison of the pharmacokinetics and phototoxicity of protoporphyrin IX metabolized from 5-aminolevulinic acid and two derivatives in human skin in vivo.
Gerscher S; Connelly JP; Griffiths J; Brown SB; MacRobert AJ; Wong G; Rhodes LE
Photochem Photobiol; 2000 Oct; 72(4):569-74. PubMed ID: 11045731
[TBL] [Abstract][Full Text] [Related]
2. A quantitative assessment of protoporphyrin IX metabolism and phototoxicity in human skin following dose-controlled delivery of the prodrugs 5-aminolaevulinic acid and 5-aminolaevulinic acid-n-pentylester.
Gerscher S; Connelly JP; Beijersbergen Van Henegouwen GM; MacRobert AJ; Watt P; Rhodes LE
Br J Dermatol; 2001 May; 144(5):983-90. PubMed ID: 11359385
[TBL] [Abstract][Full Text] [Related]
3. Iontophoretic delivery of ALA provides a quantitative model for ALA pharmacokinetics and PpIX phototoxicity in human skin.
Rhodes LE; Tsoukas MM; Anderson RR; Kollias N
J Invest Dermatol; 1997 Jan; 108(1):87-91. PubMed ID: 8980294
[TBL] [Abstract][Full Text] [Related]
4. The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy.
Choudry K; Brooke RC; Farrar W; Rhodes LE
Br J Dermatol; 2003 Jul; 149(1):124-30. PubMed ID: 12890205
[TBL] [Abstract][Full Text] [Related]
5. Topical application of 5-aminolevulinic acid hexyl ester and 5-aminolevulinic acid to normal nude mouse skin: differences in protoporphyrin IX fluorescence kinetics and the role of the stratum corneum.
van den Akker JT; Iani V; Star WM; Sterenborg HJ; Moan J
Photochem Photobiol; 2000 Nov; 72(5):681-9. PubMed ID: 11107855
[TBL] [Abstract][Full Text] [Related]
6. Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study.
Lange N; Jichlinski P; Zellweger M; Forrer M; Marti A; Guillou L; Kucera P; Wagnières G; van den Bergh H
Br J Cancer; 1999 Apr; 80(1-2):185-93. PubMed ID: 10389995
[TBL] [Abstract][Full Text] [Related]
7. In vitro/in vivo correlations between transdermal delivery of 5-aminolaevulinic acid and cutaneous protoporphyrin IX accumulation and effect of formulation.
Tsai JC; Chen IH; Wong TW; Lo YL
Br J Dermatol; 2002 May; 146(5):853-62. PubMed ID: 12000384
[TBL] [Abstract][Full Text] [Related]
8. The effects of 5-aminolevulinic acid esters on protoporphyrin IX production in human adenocarcinoma cell lines.
Brunner H; Hausmann F; Krieg RC; Endlicher E; Schölmerich J; Knuechel R; Messmann H
Photochem Photobiol; 2001 Nov; 74(5):721-5. PubMed ID: 11723801
[TBL] [Abstract][Full Text] [Related]
9. Topical application of 5-aminolevulinic acid and its methylester, hexylester and octylester derivatives: considerations for dosimetry in mouse skin model.
Juzeniene A; Juzenas P; Iani V; Moan J
Photochem Photobiol; 2002 Sep; 76(3):329-34. PubMed ID: 12403455
[TBL] [Abstract][Full Text] [Related]
10. Relationship of protoporphyrin IX synthesis to photodynamic effects by 5-aminolaevulinic acid and its esters on various cell lines derived from the skin.
Lee JB; Choi JY; Chun JS; Yun SJ; Lee SC; Oh J; Park HR
Br J Dermatol; 2008 Jul; 159(1):61-7. PubMed ID: 18489589
[TBL] [Abstract][Full Text] [Related]
11. Protoporphyrin IX fluorescence induced in basal cell carcinoma by oral delta-aminolevulinic acid.
Tope WD; Ross EV; Kollias N; Martin A; Gillies R; Anderson RR
Photochem Photobiol; 1998 Feb; 67(2):249-55. PubMed ID: 9487802
[TBL] [Abstract][Full Text] [Related]
12. Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer.
Marti A; Jichlinski P; Lange N; Ballini JP; Guillou L; Leisinger HJ; Kucera P
J Urol; 2003 Aug; 170(2 Pt 1):428-32. PubMed ID: 12853792
[TBL] [Abstract][Full Text] [Related]
13. A HCl/alcohol formulation increased 5-aminolevulinic acid skin distribution using an ex vivo full thickness porcine skin model.
Maisch T; Worlicek C; Babilas P; Landthaler M; Szeimies RM
Exp Dermatol; 2008 Oct; 17(10):813-20. PubMed ID: 18380780
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of protoporphyrin IX in nude mice after application of ALA and ALA esters.
Moan J; Ma LW; Juzeniene A; Iani V; Juzenas P; Apricena F; Peng Q
Int J Cancer; 2003 Jan; 103(1):132-5. PubMed ID: 12455066
[TBL] [Abstract][Full Text] [Related]
15. Protoporphyrin IX-accumulation in human tumor cells following topical ALA- and h-ALA-application in vivo.
Zenzen V; Zankl H
Cancer Lett; 2003 Dec; 202(1):35-42. PubMed ID: 14643024
[TBL] [Abstract][Full Text] [Related]
16. Clearance mechanism of protoporphyrin IX from mouse skin after application of 5-aminolevulinic acid.
Juzeniene A; Iani V; Moan J
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):538-45. PubMed ID: 24284108
[TBL] [Abstract][Full Text] [Related]
17. The monitoring of the accumulation of protoporphyrin IX in Walker tumours by subcutaneous administration of delta-aminolevulinic acid.
Calin MA; Gruia Ml; Herascu N; Coman T
J Exp Ther Oncol; 2004 Oct; 4(3):247-51. PubMed ID: 15724844
[TBL] [Abstract][Full Text] [Related]
18. Fluorescence characteristics and pharmacokinetic properties of a novel self-adhesive 5-ALA patch for photodynamic therapy of actinic keratoses.
Fauteck JD; Ackermann G; Birkel M; Breuer M; Moor AC; Ebeling A; Ortland C
Arch Dermatol Res; 2008 Feb; 300(2):53-60. PubMed ID: 17960406
[TBL] [Abstract][Full Text] [Related]
19. Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevulinic acid methylester on tape-stripped normal skin.
Wiegell SR; Stender IM; Na R; Wulf HC
Arch Dermatol; 2003 Sep; 139(9):1173-7. PubMed ID: 12975159
[TBL] [Abstract][Full Text] [Related]
20. Protoporphyrin IX fluorescence kinetics and localization after topical application of ALA pentyl ester and ALA on hairless mouse skin with UVB-induced early skin cancer.
van den Akker JT; de Bruijn HS; Beijersbergen van Henegouwen GM; Star WM; Sterenborg HJ
Photochem Photobiol; 2000 Sep; 72(3):399-406. PubMed ID: 10989612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
